Prognostic Significance of Fatty Liver Disease in Bariatric Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEsbjerg Hospital - University Hospital of Southern Denmark

About this trial

Prospective non-randomized intervention case control study on patients with a BMI \> 35. The intervention group/cases (n=600) is comprised of bariatric patients who undergo bariatric surgery and the control group (n=600) of age, weight and comorbidity matched patients who choose not to undergo bariatric surgery. The overall aim is to examine prevalence of the spectrum of fatty liver disease (NAFLD) in these patients and the prognostic significance of NAFLD.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age > 18 years

BMI >35 kg/m2 and referred for bariatric surgery at Hospital of South West Jutland, Denmark

Able to give written informed consent.

Age > 18 years

Disqualifiers

Active viral hepatitis

Not willing or able to consent

Contraindications to liver biopsy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Bariatric surgery

    Procedure/Surgery

    Roux en y gastric bypass or gastric sleeve operation

Treatment groups

1,200 Participants
are divided into 2 treatment groups
Group A: InterventionExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Number of participants who will die during the follow up period in case and control group

Difference in mortality between cases and controls with various NAFLD severity on biopsy.

Time frame
10 years follow up after inclusion

Secondary outcomes

1

Number of participant who will experience progressive fatty liver disease in case and control group

Difference NAFLD severity between case and control group after 10 years follow up. Simple steatosis is the mildest form and liver cirrhosis is the most serious manifestation: 1. Grade 1 steatosis 2. Grade 2 steatosis 3. Grade 3 steatosis 4. Non alcoholic steatohepatitis 5. Presence of fibrosis Kleiner grade 1-2 6. Presence of fibrosis Kleiner grade 3 7. Presence of liver cirrhosis

Time frame
10 years follow up after inclusion
2

Change in continuous reaction time measurement after bariatric surgery

Continuous reaction time measurement will measure reaction time instability and is a measure of metabolic encephalopathy. The method is a 10-minutes, computerised registration of a series of motor reaction times to an auditory stimulus, with results reported as the CRTindex (50 percentile/(90-10) percentile) as a parameter of reaction time variability. A CRT index below 1.9 i considerede abnormal a may be a sign of hepatic encephalopathy.

Time frame
10 years follow up after inclusion
3

Change in EEG after bariatric surgery

Change in mean dominant frequency(MD) on EEG spectral analysis. EEG disturbances in hepatic encephalopathy are (rated by severity)but there is no enough space here to describe it.

Time frame
24 months after surgery
4

Change in intelligence quotient after bariatric surgery

Measured by Weschlers adult intelligence scale (WAIS). An IQ if 100 i the norm. Range 50-150.

Time frame
24 months efter surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Esbjerg Hospital - University Hospital of Southern Denmark

Lead sponsor

University of Southern Denmark

Sponsor institution

University of Southern Denmark

Collaborator

Odense University Hospital

Collaborator

Esbjerg University Hospital of South-West Jutland

Collaborator